Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort.
* Context.--Following the validation of a multicolor flow cytometry (MFC) assay for measurable residual disease (MRD) in acute myeloid leukemia (AML), this study examines its clinical applicability. Objective.--To evaluate the practicality and performance of MFC-based MRD detection in AML. Design.--...
| Publicado en: | Archives of Pathology & Laboratory Medicine Vol. 150; no. 1; pp. 72 - 81 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
College of American Pathologists
Jan2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |